Greenway Medical Tech (GWAY) Misses Q2 EPS by 4c; Trims FY13 Outlook
Tweet
Share
E-mailGet Alerts GWAY Hot Sheet
Price: $20.35 --0%
Financial Fact:
Total other income: -4.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total other income: -4.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Greenway Medical Tech (NYSE: GWAY) reported Q2 EPS of $0.00, $0.04 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $32.7 million versus the consensus estimate of $35.62 million.
Greenway Medical Tech sees FY2013 EPS of $0.21-0.28, versus the consensus of $0.27. Greenway Medical Tech sees FY2013 revenue of $145-150 million, versus the consensus of $151.05 million.
For earnings history and earnings-related data on Greenway Medical Tech (GWAY) click here.
Greenway Medical Tech sees FY2013 EPS of $0.21-0.28, versus the consensus of $0.27. Greenway Medical Tech sees FY2013 revenue of $145-150 million, versus the consensus of $151.05 million.
For earnings history and earnings-related data on Greenway Medical Tech (GWAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
